COLEY PHARMACEUTICAL GMBH

Patent Applications and Registrations

Patent applications and USPTO patent grants for COLEY PHARMACEUTICAL GMBH.The latest application filed is for "cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity".

Company Profile

3.31.43

COLEY PHARMACEUTICAL GMBH - Dusseldorf DE
Coley Pharmaceutical GmbH - Langenfeld DE
Coley Pharmaceutical GmbH - Lagenfeld DE
COLEY PHARMACEUTICAL GMBH - Duesseldorf DE
Coley Pharmaceutical GmbH - Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical GmbH - Elisabeth-Seibert-Strasse 9 Lagenfeld ON
Coley Pharmaceutical GmbH - Elisabeth-Selbert-Strasse 9 Langenfeld DE
Coley Pharmaceutical GmbH - Langenfield DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity Grant 10,260,071 - Debelak , et al.	2019-04-16
CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity App 20160348115 - Debelak; Harald ; et al.	2016-12-01
CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity Grant 9,382,545 - Debelak , et al. July 5, 2	2016-07-05
Combination motif immune stimulatory oligonucleotides with improved activity Grant 8,834,900 - Krieg , et al. September 16, 2	2014-09-16
CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity App 20140163213 - Debelak; Harald ; et al.	2014-06-12
Immunostimulatory G, U-containing Oligoribonucleotides App 20140135487 - LIPFORD; GRAYSON B. ; et al.	2014-05-15
CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity Grant 8,580,268 - Debelak , et al. November 12, 2	2013-11-12
RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Grant 8,466,124 - Jurk , et al. June 18, 2	2013-06-18
Immunostimulatory oligoribonucleotides Grant 8,354,522 - Forsbach , et al. January 15, 2	2013-01-15
Immunostimulatory nucleic acids Grant 8,304,396 - Krieg , et al. November 6, 2	2012-11-06
Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages Inducing Specific Immune Modulatory Profiles App 20120258140 - Jurk; Marion ; et al.	2012-10-11
Immunostimulatory nucleic acids Grant 8,283,328 - Krieg , et al. October 9, 2	2012-10-09
Combination Motif Immune Stimulatory Oligonucleotides With Improved Activity App 20120219571 - VOLLMER; JORG ; et al.	2012-08-30
RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Grant 8,227,447 - Jurk , et al. July 24, 2	2012-07-24
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant Grant 8,202,688 - Davis , et al. June 19, 2	2012-06-19
Combination motif immune stimulatory oligonucleotides with improved activity Grant 8,198,251 - Vollmer , et al. June 12, 2	2012-06-12
C-class oligonucleotide analogs with enhanced immunostimulatory potency Grant 8,188,254 - Uhlmann , et al. May 29, 2	2012-05-29
Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages Inducing Specific Immune Modulatory Profiles App 20120121648 - Jurk; Marion ; et al.	2012-05-17
Immunostimulatory G, U-containing oligoribonucleotides Grant 8,153,141 - Lipford , et al. April 10, 2	2012-04-10
RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Grant 8,128,944 - Jurk , et al. March 6, 2	2012-03-06
Immunostimulatory Dna:rna Oligonucleotides App 20110300164 - Lipford; Grayson B. ; et al.	2011-12-08
Immunostimulatory Oligoribonucleotides App 20110206719 - Forsbach; Alexandra ; et al.	2011-08-25
Methods and products related to treatment and prevention of hepatitis C virus infection Grant 7,998,492 - Ahluwalia , et al. August 16, 2	2011-08-16
5' CpG nucleic acids and methods of use Grant 7,956,043 - Krieg , et al. June 7, 2	2011-06-07
Methods Related To Immunostimulatory Nucleic Acid-induced Interferon App 20110033421 - Hartmann; Gunther ; et al.	2011-02-10
Immunostimulatory Oligoribonucleotides App 20100316659 - Forsbach; Alexandra ; et al.	2010-12-16
Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages Inducing Specific Immune Modulatory Profiles App 20100272785 - Jurk; Marion ; et al.	2010-10-28
Process for high throughput screening of CpG-based immuno-agonist/antagonist Grant 7,820,379 - Bauer , et al. October 26, 2	2010-10-26
Semi-soft c-class immunostimulatory oligonucleotides Grant 7,795,235 - Krieg , et al. September 14, 2	2010-09-14
Methods related to immunostimulatory nucleic acid-induced interferon Grant 7,776,344 - Hartmann , et al. August 17, 2	2010-08-17
Oligoribonucleotides and uses thereof App 20100144846 - Jurk; Marion ; et al.	2010-06-10
Immunostimulatory oligoribonucleotides Grant 7,662,949 - Forsbach , et al. February 16, 2	2010-02-16
Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification App 20090306177 - Uhlmann; Eugen ; et al.	2009-12-10
Nucleic acid-lipophilic conjugates Grant 7,615,539 - Uhlmann , et al. November 10, 2	2009-11-10
Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone App 20090214578 - Bauer; Stefan	2009-08-27
Semi-soft C-class immunostimulatory oligonucleotides Grant 7,566,703 - Krieg , et al. July 28, 2	2009-07-28
Methods for enhancing antibody-induced cell lysis and treating cancer Grant 7,534,772 - Weiner , et al. May 19, 2	2009-05-19
Combination Motif Immune Stimulatory Oligonucleotides With Improved Activity App 20090087446 - VOLLMER; JORG ; et al.	2009-04-02
Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination App 20090060927 - Wagner; Hermann ; et al.	2009-03-05
CPG-like nucleic acids and methods of use thereof App 20080226649 - Schetter; Christian ; et al.	2008-09-18
Small molecule toll-like receptor (TLR) antagonists Grant 7,410,975 - Lipford , et al. August 12, 2	2008-08-12
Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist App 20080113929 - Lipford; Grayson B. ; et al.	2008-05-15
Compositions and methods for oligonucleotide formulations App 20080045473 - Uhlmann; Eugen ; et al.	2008-02-21
Small molecule toll-like receptor (TLR) antagonists App 20070232622 - Lipford; Grayson B. ; et al.	2007-10-04
Immunostimulatory nucleic acids Grant 7,271,156 - Krieg , et al. September 18, 2	2007-09-18
Methods for regulating hematopoiesis using CpG-oligonucleotides App 20070184465 - Wagner; Hermann ; et al.	2007-08-09
Immunostimulatory oligoribonucleotides App 20070142315 - Forsbach; Alexandra ; et al.	2007-06-21
Immunostimulatory nucleic acids App 20070066554 - Krieg; Arthur M. ; et al.	2007-03-22
Methods related to immunostimulatory nucleic acid-induced interferon App 20060286070 - Hartmann; Gunther ; et al.	2006-12-21
Methods and products related to treatment and prevention of hepatitis c virus infection App 20060246035 - Ahluwalia; Navneet K. ; et al.	2006-11-02
Modified oligoribonucleotide analogs with enhanced immunostimulatory activity App 20060241076 - Uhlmann; Eugen ; et al.	2006-10-26
Immunostimulatory G, U-containing oligoribonucleotides App 20060172966 - Lipford; Grayson ; et al.	2006-08-03
Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination Grant 7,001,890 - Wagner , et al. February 21, 2	2006-02-21
C-class oligonucleotide analogs with enhanced immunostimulatory potency App 20050239734 - Uhlmann, Eugen ; et al.	2005-10-27
Sequence requirements for inhibitory oligonucleotides App 20050239733 - Jurk, Marion ; et al.	2005-10-27
Methods related to immunostimulatory nucleic acid-induced interferon Grant 6,949,520 - Hartmann , et al. September 27, 2	2005-09-27
Process for high throughput screening of CpG-based immuno-agonist/antagoni- st App 20050181422 - Bauer, Stefan ; et al.	2005-08-18
Methods related to immunostimulatory nucleic acid-induced interferon App 20050169888 - Hartmann, Gunther ; et al.	2005-08-04
Small molecule toll-like receptor (TLR) antagonists App 20050119273 - Lipford, Grayson B. ; et al.	2005-06-02
Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling App 20050100983 - Bauer, Stefan ; et al.	2005-05-12
Pharmaceutical composition comprising a polynucleotide and optionally an antigen especially for vaccination App 20050054601 - Wagner, Hermann ; et al.	2005-03-10
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant App 20050043529 - Davis, Heather L. ; et al.	2005-02-24
Methods for regualting hematopoiesis using CpG-oligonucleotides App 20040234512 - Wagner, Hermann ; et al.	2004-11-25
Methods for regulating hematopoiesis using CpG-oligonucleotides App 20040235778 - Wagner, Hermann ; et al.	2004-11-25
Methods for regulating hematopoiesis using CpG-oligonucleotides App 20040235777 - Wagner, Hermann ; et al.	2004-11-25
Immunostimulatory G, U-containing oligoribonucleotides App 20030232074 - Lipford, Grayson ; et al.	2003-12-18
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant App 20030224010 - Davis, Heather L. ; et al.	2003-12-04
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant App 20030091599 - Davis, Heather L. ; et al.	2003-05-15
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant Grant 6,406,705 - Davis , et al. June 18, 2	2002-06-18
Vectors and methods for immunization or therapeutic protocols Grant 6,339,068 - Krieg , et al. January 15, 2	2002-01-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.